Promega Corporation

TransFast™ Transfection Reagent

The TransFast™ Transfection Reagent is composed of the synthetic cationic lipid, (+)-N,N [bis (2-hydroxyethyl)]-N-methyl-N- [2,3-di(tetradecanoyloxy)propyl] ammonium iodide and the neutral lipid, DOPE. The TransFast™ Reagent is supplied as a dried lipid film that forms multilamellar vesicles upon hydration with water. Cationic liposomes designed for transfection, such as the TransFast™ Reagent, are more versatile than many other traditional transfection methods. The advantages include flexibility in the macromolecules that are delivered, in vitro and in vivo applications, ability to more reproducibly transfect ce...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega Biotech Iberica only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

TransFast™ Transfection Reagent

Close Window

TransFast™ Transfection Reagent

 Components

  • Nuclease-Free Water

    E111B2 x 1ml
  • TransFast™ Transfection Reagent

    E243A3 x 0.4mg
Close Window
  • This product can be added to a

  • Helix Freezer

This product is available through the Promega Helix onsite stocking program in a –20°C Helix Freezer. The program offers numerous convenient solutions to meet your lab's needs. Helix Freezers are available in two sizes: 5.7 cubic ft. or 9.7 cubic ft.


Click here to learn more about the Helix Collection »


Already a Helix Customer?

Request to add this product to your Helix »


1.2mg
- E2431 € 410,00 Add to cart


You Also May Be Interested In

Storage Conditions

Store at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

E2431 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

E2431 The cationic lipid component of the TransFast™ Transfection Reagent is covered by U.S. Pat. Nos. 5,824,812, 5,869,715 and 5,925,623, Australian Pat. No. 713093, Canadian Pat. No. 2,233,064 and pending foreign patents.

Prefer a different language?

Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.